Added to YB: 2017-05-12
Pitch date: 2017-05-12
EYPT:US [bullish]
EyePoint, Inc.
+33.64%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
EyePoint, Inc. engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases.
Market Cap
$1.1B
Pitch Price
$11.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.21
P/E
-4.32
EV/Sales
21.03
Sector
Pharmaceuticals
Category
N/A
Show full summary:
EyePoint Pharmaceuticals, Inc. EYPT:US
A summary for this pitch has not been created yet.
Read full article (0 min)